JWH-081 is an analgesic chemical from the naphthoylindole family, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors.[3] With a Ki of 1.2nM it is fairly selective for the CB1 subtype, its affinity at this subtype is measured at approximately 10x the affinity at CB2(12.4nM).[4] It was discovered by and named after John W. Huffman.
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.230.181 |
Chemical and physical data | |
Formula | C25H25NO2 |
Molar mass | 371.480 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |
JWH-081 may be neurotoxic to animals when administered in high doses.[5]
In the United States, JWH-081 is a Schedule I Controlled Substance.[6]
As of October 2015, JWH-081 is a controlled substance in China.[7]